دورية أكاديمية
Time to switch to second-line antiretroviral therapy in children with human immunodeficiency virus in Europe and Thailand
| العنوان: | Time to switch to second-line antiretroviral therapy in children with human immunodeficiency virus in Europe and Thailand |
|---|---|
| المؤلفون: | Goetghebuer T., Hainaut M., Van Der Kelen E., Delforge M., Warszawski J., Le Chenadec J., Ramos E., Dialla O., Wack T., Laurent C., Selmi L. A., Leymarie I., Benali F. A., Brossard M., Boufassa L., Floch-Tudal C., Firtion G., Hau I., Chace A., Bolot P., Blanche S., Granier M., Labrune P., Lachassine E., Dollfus C., Levine M., Fourcade C., Heller-Roussin B., Runel-Belliard C., Tricoire J., Monpoux F., Chirouze C., Reliquet V., Brouard J., Kebaili K., Fialaire P., Lalande M., Mazingue F., Partisani M. L., Konigs C., Schultze-Strasser S., Baumann U., Niehues T., Neubert J., Kobbe R., Feiterna-Sperling C., Buchholz B., Notheis G., Naver L., Soeria-Atmadja S., Hagas V., Scott S., Vaughan Y., Welch S., Laycock N., Bernatoniene J., Finn A., Hutchison L., Sharpe G., Williams A., Lyall E. G. H., Seery P., Lewis P., Miles K., Subramaniam B., Hutchinson L., Ward P., Sloper K., Gopal G., Doherty C., Hague R., Price V., Bamford A., Bundy H., Clapson M., Flynn J., Gibb D. M., Klein N., Novelli V., Shingadia D., Ainsley-Walker P., Tovey P., Gurtin D., Garside J. P., Fall A., Porter D., Segal S., Ball C., Hawkins S., Chetcuti P., Dowie M., Bandi S., McCabe A., Eisenhut M., Handforth J., Roy P. K., Flood T., Pickering A., Liebeschuetz S., Kavanagh C., Murphy C., Rowson K., Tan T., Daniels J., Lees Y., Kerr E., Thompson F., Le Provost M., Cliffe L., Smyth A., Stafford S., Freeman A., Reddy T., Fidler K., Christie S., Gordon A., Rogahn D., Harris S., Collinson A., Jones L., Offerman B., Van Someren V., Benson C., Riordan A., Riddell A., O'Connor R., Brown N., Ibberson L., Shackley F., Faust S. N., Hancock J., Doerholt K., Donaghy S., Prime K., Sharland M., Storey S., Gorman S., Monrose C., Tudor-Williams G., Walters S., Cross R., Menson E., Broomhall J., Scott D., Stroobant J., Bridgwood A., McMaster P., Evans J., Gardiner T., Jones R., Gardiner K., Giaquinto C. |
| المساهمون: | Goetghebuer, T., Hainaut, M., Van Der Kelen, E., Delforge, M., Warszawski, J., Le Chenadec, J., Ramos, E., Dialla, O., Wack, T., Laurent, C., Selmi, L. A., Leymarie, I., Benali, F. A., Brossard, M., Boufassa, L., Floch-Tudal, C., Firtion, G., Hau, I., Chace, A., Bolot, P., Blanche, S., Granier, M., Labrune, P., Lachassine, E., Dollfus, C., Levine, M., Fourcade, C., Heller-Roussin, B., Runel-Belliard, C., Tricoire, J., Monpoux, F., Chirouze, C., Reliquet, V., Brouard, J., Kebaili, K., Fialaire, P., Lalande, M., Mazingue, F., Partisani, M. L., Konigs, C., Schultze-Strasser, S., Baumann, U., Niehues, T., Neubert, J., Kobbe, R., Feiterna-Sperling, C., Buchholz, B., Notheis, G., Naver, L., Soeria-Atmadja, S., Hagas, V., Scott, S., Vaughan, Y., Welch, S., Laycock, N., Bernatoniene, J., Finn, A., Hutchison, L., Sharpe, G., Williams, A., Lyall, E. G. H., Seery, P., Topley, Lewi, Miles, K., Subramaniam, B., Hutchinson, L., Ward, P., Sloper, K., Gopal, G., Doherty, C., Hague, R., Price, V., Bamford, A., Bundy, H., Clapson, M., Flynn, J., Gibb, D. M., Klein, N., Novelli, V., Shingadia, D., Ainsley-Walker, P., Tovey, P., Gurtin, D., Garside, J. P., Fall, A., Porter, D., Segal, S., Ball, C., Hawkins, S., Chetcuti, P., Dowie, M., Bandi, S., Mccabe, A., Eisenhut, M., Handforth, J., Roy, P. K., Flood, T., Pickering, A., Liebeschuetz, S. |
| بيانات النشر: | Oxford University Press |
| سنة النشر: | 2018 |
| المجموعة: | Padua Research Archive (IRIS - Università degli Studi di Padova) |
| مصطلحات موضوعية: | Antiretroviral therapy, Children, HIV, Second-line, Switch, Age Factor, Anti-HIV Agent, Child, Preschool, Cohort Studie, Drug Resistance, Viral, Drug Substitution, Europe, Female, HIV Infection, Human, Infant, Male, Reverse Transcriptase Inhibitor, Thailand, Time Factor, Treatment Failure, Viral Load, Highly Active |
| الوصف: | Background. Data on durability of first-line antiretroviral therapy (ART) in children with human immunodeficiency virus (HIV) are limited. We assessed time to switch to second-line therapy in 16 European countries and Thailand. Methods. Children aged <18 years initiating combination ART (.2 nucleoside reverse transcriptase inhibitors [NRTIs] plus nonnucleoside reverse transcriptase inhibitor [NNRTI] or boosted protease inhibitor [PI]) were included. Switch to second-line was defined as (i) change across drug class (PI to NNRTI or vice versa) or within PI class plus change of .1 NRTI; (ii) change from single to dual PI; or (iii) addition of a new drug class. Cumulative incidence of switch was calculated with death and loss to follow-up as competing risks. Results. Of 3668 children included, median age at ART initiation was 6.1 (interquartile range (IQR), 1.7.10.5) years. Initial regimens were 32% PI based, 34% nevirapine (NVP) based, and 33% efavirenz based. Median duration of follow-up was 5.4 (IQR, 2.9.8.3) years. Cumulative incidence of switch at 5 years was 21% (95% confidence interval, 20%.23%), with significant regional variations. Median time to switch was 30 (IQR, 16.58) months; two-thirds of switches were related to treatment failure. In multivariable analysis, older age, severe immunosuppression and higher viral load (VL) at ART start, and NVP-based initial regimens were associated with increased risk of switch. Conclusions. One in 5 children switched to a second-line regimen by 5 years of ART, with two-thirds failure related. Advanced HIV, older age, and NVP-based regimens were associated with increased risk of switch. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | STAMPA |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/29029056; info:eu-repo/semantics/altIdentifier/wos/WOS:000425383800016; volume:66; issue:4; firstpage:594; lastpage:603; numberofpages:10; journal:CLINICAL INFECTIOUS DISEASES; http://hdl.handle.net/11577/3339246Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85046701803 |
| DOI: | 10.1093/cid/cix854 |
| الإتاحة: | https://doi.org/10.1093/cid/cix854Test http://hdl.handle.net/11577/3339246Test |
| رقم الانضمام: | edsbas.31A44A14 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/cid/cix854 |
|---|